Functional evaluation of various ICAM3 transcript variants in diffuse large B-Cell lymphoma

References

• Hawkes EA, Barraclough A, Sehn LH. Limited-stage diffuse large B-cell lymphoma. Blood. 2022;139(6):822–834.
   PubMed Web of Science ®Google Scholar
• Bai Z, Zhou Y. A systematic review of primary gastric diffuse large B-cell lymphoma: clinical diagnosis, staging, treatment and prognostic factors. Leuk Res. 2021;111:106716.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA A Cancer J Clinicians. 2022;72(1):7–33.
   PubMed Web of Science ®Google Scholar
• Li L, Luo D, Jin A, et al. Clinical significance and functional validation of inorganic pyrophosphatase in diffuse large B cell lymphoma in humans. Cytotechnology. 2018;70(2):641–649.
   PubMed Web of Science ®Google Scholar
• Schneider T, Rosta A, Losonczy H, et al. Efficacy and tolerability of a 2-year rituximab maintenance therapy in patients with advanced follicular lymphoma after induction of response with rituximab-containing first line-regimens (HUSOM study). Pathol Oncol Res. 2018;24(2):199–205.
   PubMed Web of Science ®Google Scholar
• Iacoboni G, Zucca E, Ghielmini M, et al. Methodology of clinical trials evaluating the incorporation of new drugs in the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL): a critical review. Ann Oncol. 2018;29(5):1120–1129.
   PubMed Web of Science ®Google Scholar
• Xiao X, Mruk DD, Cheng CY. Intercellular adhesion molecules (ICAMs) and spermatogenesis. Hum Reprod Update. 2013;19(2):167–186.
   PubMed Web of Science ®Google Scholar
• Skubitz KM, Ahmed K, Campbell KD, et al. CD50 (ICAM-3) is phosphorylated on tyrosine and is associated with tyrosine kinase activity in human neutrophils. J Immunol. 1995;154(6):2888–2895.
   PubMed Web of Science ®Google Scholar
• Greenwood J, Amos CL, Walters CE, et al. Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration. J Immunol. 2003;171(4):2099–2108.
   PubMed Web of Science ®Google Scholar
• de Fougerolles AR, Klickstein LB, Springer TA. Cloning and expression of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family counter-receptors for lymphocyte function-associated antigen 1. J Exp Med. 1993;177(4):1187–1192.
   PubMed Web of Science ®Google Scholar
• Montoya MC, Sancho D, Bonello G, et al. Role of ICAM-3 in the initial interaction of T lymphocytes and APCs. Nat Immunol. 2002;3(2):159–168.
   PubMed Web of Science ®Google Scholar
• Shen W, Zhang X, Du R, et al. ICAM3 mediates tumor metastasis via a LFA-1-ICAM3-ERM dependent manner. Biochim Biophys Acta Mol Basis Dis. 2018;1864(8):2566–2578.
   PubMed Web of Science ®Google Scholar
• Shen W, Xie J, Zhao S, et al. ICAM3 mediates inflammatory signaling to promote cancer cell stemness. Cancer Lett. 2018;422:29–43.
   PubMed Web of Science ®Google Scholar
• Park JK, Park SH, So K, et al. ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int J Oncol. 2010 Jan;36(1):181–92.
   PubMed Web of Science ®Google Scholar
• Ahn KC, Choi JY, Kim JS, et al. ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis. Biochem Biophys Res Commun. 2013;441(2):507–513.
   PubMed Web of Science ®Google Scholar
• Kristof E, Zahuczky G, Katona K, et al. Novel role of ICAM3 and LFA-1 in the clearance of apoptotic neutrophils by human macrophages. Apoptosis. 2013;18(10):1235–1251.
   PubMed Web of Science ®Google Scholar
• Shen W, Chang A, Wang J, et al. TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer. Oncogenesis. 2015;4:e173.
   PubMed Web of Science ®Google Scholar
• Shen W, Du R, Li J, et al. TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways. Signal Transduct Target Ther. 2016;1:16013.
   PubMed Web of Science ®Google Scholar
• Luo D, Liu D, Shi W, et al. PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner. Oncogenesis. 2019;8(10):53.
   PubMedGoogle Scholar
• Shen W, Zhang X, Tang J, et al. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis. Theranostics. 2021;11(5):2297–2317.
   PubMed Web of Science ®Google Scholar
• Zhang X, Du R, Luo N, et al. Aspirin mediates histone methylation that inhibits inflammation-related stemness gene expression to diminish cancer stemness via COX-independent manner. Stem Cell Res Ther. 2020;11(1):370.
   PubMed Web of Science ®Google Scholar
• Shen W, Zhang X, Du R, et al. Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner. Br J Cancer. 2020;123(5):730–741.
   PubMed Web of Science ®Google Scholar
• Oliva S, Puzzovivo A, Gerardi C, et al. Late cardiological sequelae and long-term monitoring in classical Hodgkin lymphoma and diffuse large B-Cell lymphoma survivors: a systematic review by the Fondazione Italiana Linfomi. Cancers. 2021;14(1):61.
   PubMed Web of Science ®Google Scholar
• Eyre TA, Wilson W, Kirkwood AA, et al. Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP. Blood Advances. 2021;5(8):2229–2236.
   PubMed Web of Science ®Google Scholar
• Thakkar A, Cui Z, Peeke SZ, et al. Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting. Stem Cell Investig. 2021;8:18–18.
   PubMedGoogle Scholar
• Xiang C, Ni H, Wang Z, et al. Agent repurposing for the treatment of advanced stage diffuse large B-Cell lymphoma based on gene expression and network perturbation analysis. Front Genet. 2021;12:756784.
   PubMed Web of Science ®Google Scholar
• Meriranta L, Alkodsi A, Pasanen A, et al. Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma. Blood. 2022 Mar 24;139(12):1863–1877.
   PubMed Web of Science ®Google Scholar
• Chiappella A, Diop F, Agostinelli C, et al. Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. Br J Haematol. 2022;196(5):1184–1193.
   PubMed Web of Science ®Google Scholar
• Sun X, Siri S, Hurst A, et al. Heat shock protein 22 in physiological and pathological hearts: small molecule, large potentials. Cells. 2021;11(1):114.
   PubMed Web of Science ®Google Scholar
• Danyaei A, Teimoori A, Khanbabaei H, et al. Effect of ionizing radiation on the transcript variants expression of p21 gene. Asian Pac J Cancer Prev. 2021;22(11):3717–3722.
   PubMedGoogle Scholar